{"id":19909,"date":"2026-07-15T14:29:49","date_gmt":"2026-07-15T14:29:49","guid":{"rendered":"https:\/\/www.peakpoint.pk\/en\/?p=19909"},"modified":"2026-07-15T14:29:49","modified_gmt":"2026-07-15T14:29:49","slug":"pakistan-to-host-major-china-health-investment-conference-on-july-17-18","status":"publish","type":"post","link":"https:\/\/www.peakpoint.pk\/en\/?p=19909","title":{"rendered":"Pakistan to Host Major China Health Investment Conference on July 17-18"},"content":{"rendered":"

By: Nadeem Tanoli<\/strong><\/p>\n

Islamabad: Pakistan will host a major two day business conference with China on July 17 and 18 to promote investment and cooperation in medicines, vaccines, medical equipment and other areas of the health sector.<\/p>\n

Around 160 Chinese companies, represented by nearly 180 delegates, are expected to participate in the conference. About 340 Pakistani companies and business representatives will also attend, taking the total number of participants to around 500.<\/p>\n

The details were shared during a press conference addressed by Federal Minister for National Health Services Mustafa Kamal, Special Assistant to the Prime Minister on Industries and Production Haroon Akhtar Khan and Federal Minister for the Board of Investment Qaiser Ahmed Sheikh.<\/p>\n

Officials said the conference would be different from traditional business events because participating Pakistani and Chinese companies had already been in contact with each other for about one month.<\/p>\n

They said the companies would not meet for the first time at the conference. Instead, they had already discussed possible projects, partnerships and investment opportunities.<\/p>\n

The conference will focus on six main areas of healthcare and pharmaceutical production. These areas include active pharmaceutical ingredients, biotechnology and vaccines, medical devices and advanced technology, generic medicines, clinical trials and traditional herbal medicines.<\/p>\n

Active pharmaceutical ingredients, commonly called APIs, are the main raw materials used to produce medicines. Health Minister Mustafa Kamal said Pakistan manufactures around 85 per cent of its medicines locally, but imports about 90 per cent of the raw materials needed to make them.<\/p>\n

He said local production of these materials could reduce Pakistan\u2019s import bill, save foreign currency, create jobs and possibly lower production costs. The minister expected companies to sign business agreements during the conference rather than limiting the event to general discussions or non-binding memorandums of understanding.<\/p>\n

He said detailed preparations had been underway for five to six weeks and several meetings had been held between the ministries, government departments and organisers. The Pakistan Embassy in China, the Ministry of Foreign Affairs, the Board of Investment, the Trade Development Authority of Pakistan, the Drug Regulatory Authority of Pakistan and other departments are involved in organising the event.<\/p>\n

Officials said investment opportunities would also be presented in biotechnology, vaccines and modern medical devices. Officials said seven or eight participating companies had shown interest in manufacturing vaccines in Pakistan.<\/p>\n

He said Chinese companies were also interested in producing pharmaceutical raw materials and carrying out clinical trials in the country. The government believes that local production will help Pakistan reduce its dependence on imported medicines, equipment and raw materials.<\/p>\n

Haroon Akhtar said the government was following around 600 agreements and memorandums signed with China during the past eight months. According to him, nearly 30 per cent of the projects had entered the implementation stage, including land acquisition and the start of construction work.<\/p>\n

He also said Pakistan had received $3.65 billion in foreign direct investment after 11 years, while agreements and joint ventures worth about $9 billion had emerged from an earlier conference in Beijing. These figures were presented by the minister during the press briefing.<\/p>\n

Qaiser Ahmed Sheikh said the government was also working to support small and medium sized businesses and attract investment in export based industries. He said Pakistan needed longterm economic policies and greater cooperation between political parties to achieve steady economic growth.<\/p>\n

The ministers said the government was trying to simplify business regulations and reduce delays in licences and approvals. They also highlighted the Karachi Industrial Park, where land is expected to be offered through a lease system instead of being sold.<\/p>\n

Officials said the model was designed to ensure that land was used for factories rather than being purchased for resale at higher prices. Companies receiving land would be required to establish industries within a fixed period and meet export targets.<\/p>\n

During the press conference, journalists raised questions about medicine prices, the quality of locally produced drugs and whether foreign investment would directly benefit ordinary people.<\/p>\n

Mustafa Kamal said the pharmaceutical industry had grown by 38 per cent during the year.\u00a0He added that companies accused of unusually large price increases had been issued show cause notices and would be required to explain their actions.<\/p>\n

The minister said future investment in local raw material production and medical manufacturing could create jobs, save dollars and strengthen the health sector.\u00a0The government expects the July 17-18 conference to produce new agreements and joint projects between Pakistani and Chinese companies.<\/p>\n","protected":false},"excerpt":{"rendered":"

By: Nadeem Tanoli Islamabad: Pakistan will host a major two day business conference with China on July 17 and 18 to promote investment and cooperation in medicines, vaccines, medical equipment and other areas of the health sector. Around 160 Chinese companies, represented by nearly 180 delegates, are expected to participate in the conference. About 340 …<\/p>\n","protected":false},"author":7,"featured_media":19910,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[2043],"class_list":["post-19909","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-education","tag-healthcaregovernance"],"_links":{"self":[{"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=\/wp\/v2\/posts\/19909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19909"}],"version-history":[{"count":1,"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=\/wp\/v2\/posts\/19909\/revisions"}],"predecessor-version":[{"id":19911,"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=\/wp\/v2\/posts\/19909\/revisions\/19911"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=\/wp\/v2\/media\/19910"}],"wp:attachment":[{"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}